Skip to main content

Table 1 Participant demographic data

From: Feasibility of ABLE 1.0—a program aiming at enhancing the ability to perform activities of daily living in persons with chronic conditions

Variable

Clients

OTs/OTSs

Total (n = 30)

Completers (n = 20)

Dropouts (n = 10)

OTs (n = 2)

OTSs (n = 5)

Gender: Female, n (%)

21 (70)

14 (70)

7 (70)

2 (100)

5 (100)

Age: Mediana (range)

72 (55–85)

73 (55–85)

70 (55–85)

52 (43–61)

23 (22–24)

Diagnosis b: n (%)

Neurologic

8 (27)

5 (25)

3 (30)

  

Medical

12 (40)

8 (40)

4 (40)

  

Musculoskeletal

10 (33)

7 (35)

3 (30)

  

Civic status: n (%)

Living alone

17 (57)

12 (60)

5 (50)

  

Living with a partner

13 (43)

8 (40)

5 (50)

  

Job situation: n (%)

     

Working

1c (3)

0

1c (10)

  

Sick leave

2 (7)

2 (10)

0

  

Senior citizen

27 (90)

18 (90)

9 (90)

  

Assistance in the homed: n (%)

26 (87)

19 (95)

7 (70)

  

Spouse

8 (31)

5 (26)

3 (30)

  

Relatives

16 (62)

11 (58)

5 (50)

  

Friends

10 (38)

9 (47)

1 (10)

  

Home care

11 (42)

8 (42)

3 (30)

  

Hired house keeper/gardener

19 (73)

13 (68)

6 (60)

  

Self-reported general health

Mediana (range)

4 (3–5)

4 (3–5)

4 (3–5)

  

Years as OT: Mean (range)

   

18 (16–20)

 

Years working with clients with chronic conditions: Mean (Range)

   

18 (16–20)

 

AMPS ADL Motor abilitye: mean (SD)

0.92 (0.56)

0.93 (0.51)

0.91 (0.70)

  

AMPS ADL Process abilitye: mean (SD)

0.74 (0.37)

0.73 (0.38)

0.78 (0.38)

  

ADL-If: mean (SD)

2.69 (1.45)

2.62 (1.63)

2.83 (1.07)

  
  1. AMPS Assessment of Motor and Process Skills, OTs occupational therapists, OTSs occupational therapy students
  2. aBased on median and range due to lack of normal distribution in data/due to ordinal data.
  3. bSeveral of the clients had more than one diagnosis. The diagnoses listed above are the ones that the clients perceived to affect their everyday life the most
  4. cOne client was working 9 hours a week
  5. dClients could mark all relevant categories
  6. eAMPS at baseline
  7. fADL-I at baseline